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Objectives: Pulmonary vascular resistance decreases dramatically after pulmonary
thromboendarterectomy and further improves in time. This may reflect the slow
regression of postobstructive pulmonary vasculopathy. We hypothesized that pos-
tobstructive pulmonary vasculopathy may regress after reperfusion in a piglet model
of chronic (5 weeks) left pulmonary artery obstruction.
Methods: The ligated left pulmonary artery was reimplanted into the pulmonary
arterial trunk. Pulmonary artery blood flow and pressure were measured 2 days and
5 weeks after reperfusion. Pulmonary artery smooth muscle thickness, endothelium-
dependent relaxation, and left lung endothelial nitric oxide synthase activity and
expression were assessed 5 weeks after ligation (n  10) and 5 weeks after
reperfusion (n  10), and compared with a sham group (n  10). Patency of the
anastomoses and systemic blood supply to the lung were assessed by pulmonary
angiography and nonselective thoracic aortography, respectively.
Results: Angiography showed that pulmonary artery anastomoses were patent in all
animals. Five weeks after reperfusion, left pulmonary blood flows were similar to
those in the sham animals, and systemic blood supply to the left lung decreased. Left
pulmonary vascular resistance decreased by 50% at 5 weeks after reperfusion
compared with 2 days after reperfusion (P .0009). Medial muscle thickness of the
left pulmonary artery greater than 600 m increased 5 weeks after ligation and
regressed to sham values 5 weeks after reperfusion (P  .001). Endothelium-
dependent relaxation was only partially restored 5 weeks after reperfusion, whereas
left lung endothelial nitric oxide synthase expressions and activities returned to
sham values.
Conclusions: This study shows that postobstructive pulmonary vasculopathy induced
by ligation of the pulmonary artery for 5 weeks regresses after reperfusion, accounting
for the progressive improvement in hemodynamics after thromboendarterectomy.
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Pulmonary thromboendarterectomy is an effec-tive treatment for most patients with chronicthromboembolic pulmonary hypertension,providing long-term hemodynamic and func-tional benefits and greater life expectancy.1-3Pulmonary vascular resistance (PVR) de-
creases dramatically after thromboendarterectomy and fur-
ther improves after the operation, with values restored to
normal or near normal levels after 1 year.4 The initial
decrease in PVR is caused by the reestablishment of the
pulmonary circulation in a previously obstructed vascular
bed, whereas the long-term progressive improvement may
reflect the slow regression of the functional and structural
changes that develop in the ischemic vascular bed.
The alterations described distal to the obstruction in
chronic pulmonary thromboembolic hypertension have been
reproduced in animal models by unilateral ligation of 1
pulmonary artery (PA). This has been termed “postobstruc-
tive pulmonary vasculopathy” and includes the develop-
ment of precapillary bronchial-to-pulmonary vascular anas-
tomoses, PA remodeling, and abnormal PA vasoreactivity
with dysfunction of the pulmonary endothelium.5,6 We hy-
pothesized that the progressive decrease in PVR that fol-
lows the initial dramatic improvement after pulmonary
thromboendarterectomy is related to regression of the pos-
tobstructive pulmonary vasculopathic abnormalities. To test
this hypothesis, we assessed pulmonary hemodynamics, PA
vasoreactivity, endothelial nitric oxide synthase (eNOS)
function and expression, and morphologic changes in the
PA bed of the left lung 5 weeks after ligation of the left PA
and 5 weeks after in situ revascularization.
Materials and Methods
Thirty piglets (Large White, weighing 21.8  3.9 kg SEM) were
used. The study complied with the “Principles of Laboratory
Animal Care,” developed by the National Society for Medical
Research, and the “Guide for the Care and Use of Laboratory
Animals,” written by the Institute of Laboratory Animal Resources
and published by the National Institutes of Health (publication No.
86-23, revised in 1985).
Study Groups
The piglets were randomly allocated to 3 groups (n  10 in each).
The first group included animals that were studied 5 weeks after
ligation of the left PA (ligated group). The second group included
animals that were studied 5 weeks after ligation of the left PA
followed by reanastomosis after 5 weeks (revascularized group).
The third group included animals that were studied 5 weeks after
dissection of the left PA without ligation (sham group).
Surgical Procedures
Left PA ligation was performed as previously described.7 Briefly,
anesthesia was induced with intramuscular ketamine (100 mg/kg)
and maintained with intravenous pentobarbital (10 mg/kg bolus,
followed by a continuous infusion of 0.1 mg · kg · min). The
animals were paralyzed with pancuronium (0.3 mg/kg). After
endotracheal intubation, intermittent positive-pressure ventilation
was provided (MMS RET 107 ventilator, MMS, Pau, France) at a
tidal volume of 15 mL/kg, a respiratory rate of 18 cycles/min, and
an FIO2 of 0.5. Body temperature was kept constant at 37°C. A
midline sternotomy was performed under sterile conditions, the
pericardium was opened, and the intrapericardial left PA was
dissected and ligated using nonabsorbable suture. The chest was
closed, and the animals were allowed to recover.
Reanastomosis of the chronically ligated left PA was per-
formed as described by Alley and colleagues.8 Briefly, a left
posterolateral thoracotomy was performed through the fourth in-
tercostal space. To avoid damaging the new bronchial collaterals,
particularly prominent over the pericardium and near the pulmo-
nary hilum, dissection was restricted to the first 2 cm of the left PA
beyond the point of ligation and to the adjacent PA trunk. After
systemic heparinization, the origin of the ligated left PA was
excised, the left artery was totally clamped, and the PA trunk was
partially clamped. The left PA was reimplanted end-to-side into
the PA trunk using a 7-0 polypropylene running suture. Chest tube
drainage was established, and the thoracotomy was closed. The
animal was allowed to recover, and the chest tube was removed 24
hours later. To avoid postoperative occlusion of the anastomosis,
the animals were anticoagulated with fractionated heparin until
harvesting of the lungs.
Hemodynamic Measurements and Harvesting of the
Lungs
The pigs were anesthetized as previously described. A midline
sternotomy was performed. Left and right PA blood flows were
measured using a flow probe (Transonic System Inc, Ithaca, NY);
right and left PA pressures (PAPs) were measured by direct
puncture 1 cm downstream from the anastomotic site. The PVR
of the right and left lungs was calculated as the mean PAP of
each lung divided by the respective PA flows. Pulmonary he-
modynamics were measured 2 days and 5 weeks after revascu-
larization.
Nonselective thoracic aortography was performed 5 weeks
after ligation of the left PA and 5 weeks after in situ revascular-
ization to examine the bronchial-to-pulmonary anastomoses. After
heparinization, the animals were exsanguinated, and the lungs
were rapidly removed from the chest. Patency of the anastomosis
was assessed by visual inspection and pulmonary angiography.
Light Microscopy and Morphometry
A total of 16 animals were used for this part of the study (8 animals
in each of the ligated and the revascularized groups). At the time
of euthanasia, the right and left lower lobes were fixed by instil-
lation of 4% paraformaldehyde in phosphate-buffered saline
through the bronchi at a pressure of 25 cm H2O until distended.
The bronchi were ligated, and the lungs were left to fix for 12 to
24 hours. The lungs were then cut into 1 cm-thick slices, and 10 to
15 random sections were taken from the midsagittal slice. These
were processed using routine histologic techniques and embedded
in paraffin; from the blocks, 5 m-thick sections were cut and
stained with hematoxylin-eosin or Verhoeff elastic stain. The
microscopic slides were grouped by lobe, randomized, and coded,
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and the sections were examined without knowledge of the exper-
imental group.
A calibrated ocular micrometer on a Leitz optical microscope
(Wetzlar, Germany) was used for the morphometric measure-
ments, as previously described.5,9 The slides were systematically
scanned for the measurements on the PAs, which were assessed
and categorized on the basis of their associations with airways. In
each lobe, we intended to find 25 arteries accompanying respira-
tory bronchioles, 25 arteries accompanying bronchioles, and 15
arteries accompanying bronchi. Each artery was also classified as
muscular (75% of circumference with media), partially muscular
(25%-75% media), or nonmuscular (25% media), and divided
into size categories of less than 200 m, 201 to 400 m, and
greater than 600 m. We measured the outer diameter of these
arteries at the external border of the media and the medial thick-
ness (MT) of all muscular PAs with circular cross-sections or a
long-to-short ratio less than 3:1. We studied 1636 PAs. From these
measured data, we first compared the MT between groups accord-
ing to the class of arterial diameter. Second, we assessed the
peripheral muscularization in these PAs by plotting the percentage
of each type of vessel in each category of airway and the relation-
ship between arterial diameter and type.
Isolated PA Ring Studies
Isolated PA ring studies were performed as previously described.6
Briefly, at the end of each experiment, intra-PA segments were
dissected out and placed in warm Krebs-Henseleit buffer com-
posed of NaCl, 118.3 mmol/L; KCL, 4.7 mmol/L; CaCl2, 1.5
mmol/L; NaHCO3, 25 mmol/L; MgSO4, 1.1 mmol/L; KH2PO4,
1.2 mmol/L; and glucose, 5.6 mmol/L. Isolated PAs were cleaned
and cut into rings 3 to 4 mm in length (1-2 mm outer diameter); 3
to 4 rings were obtained from each animal. The rings were then
mounted on stainless steel hooks, suspended in 10-mL tissue baths,
and connected to force-displacement transducers (LB-5, Showa-
sokki, Tokyo, Japan) to measure force change using a chart re-
corder (LR 4210, Yokogawa, Tokyo, Japan). The baths were filled
with 10 mL of Krebs-Henseleit buffer and aerated at 37°C with a
mixture of 95% O2 and 5% CO2. PA rings were initially stretched
to produce a preload of 1g of force and allowed to equilibrate for
60 to 90 minutes. Pilot studies involving length tension analysis of
PA rings showed that this amount of preload provided an optimal
resting tension, which was also similar to the optimal resting
tension (1.060  0.040g) reported by Liu and colleagues10 in
piglet PA rings. During this period, the Krebs-Henseleit buffer in
the tissue baths was changed every 10 minutes. After incubation
with indomethacin (105 mol/L) for 60 minutes, a concentration-
response curve to the thromboxane analog U46619 (109 mol/L-
106 mol/L) was constructed. The rings were then washed, and the
developed force was allowed to return to baseline. Next, the rings
were precontracted with U46619 to generate approximately 1g of
developed force. Once a stable contraction was obtained, cumula-
tive doses of acetylcholine (109-104 mol/L), endothelium-de-
pendent vasodilator calcium ionophore A23187 (1010 mol/L-
3.107 mol/L), or endothelium-independent vasodilator sodium
nitroprusside (109 mol/L-104 mol/L) were added to the bath,
and changes in endothelium-dependent relaxation were assessed.
These rings were washed again and allowed to equilibrate to
baseline levels.
In addition to the change in force, responses were assessed on
the basis of determination of the concentration that produced 50%
of the maximal response (EC50) extrapolated from a plot of log
concentration versus percentage of maximal response. The con-
tractile responses to U46619 were expressed in absolute values
(milligrams), and the maximum relaxation to acetylcholine,
A23187, and sodium nitroprusside was expressed as the percent-
age of the U46619-induced precontraction (0% indicated no relax-
ation and 100% indicated relaxation equal in magnitude to the
amount of precontraction).
Drugs
A23187 (calcium ionophore), sodium nitroprusside, acetylcholine
hydrochloride, and indomethacin were purchased from Sigma
Chemical Company (St Louis, Mo), and U46619 was provided by
Upjohn (Kalamazoo, Mich).
Measurement of eNOS Activity
Calcium-dependent and -independent NOS activities were deter-
mined in left lung homogenates from the 3 groups as previously
described.6 The lungs were frozen in liquid nitrogen immediately
after removal. Tissue was homogenized on ice, using an Ultraturax
blender (Kinematica, Lucerne, Switzerland), in 4 volumes of
buffer containing 50 mmol/L Tris-HCL (pH 7.4), 0.1 mmol/L
ethylenediaminetetraacetic acid (EDTA), 0.1 mmol/L ethyleneg-
lycoltetraacetic acid (EGTA), 0.1% 2-mercaptoethanol, 1 mol/L
leupeptin, 1 mol/L pepstatin A, and 1 mmol/L phenylmethylsul-
fonyl fluoride. The homogenate was centrifuged at 100,000g for 1
hour at 5°C. To remove soluble proteins, the pellet was resus-
pended in homogenization buffer containing 1 mol/L KCl and
allowed to stand on ice for 5 minutes before centrifugation at
100,000g for 30 minutes at 5°C. The supernatant fraction was
discarded, and the pellet (membrane fraction) was resuspended in
homogenization buffer containing the detergent CHAPS (20
mmol/L), 1 mol/L KCl, and glycerol (10% vol/vol) and then
allowed to stand on ice for 30 minutes before centrifugation at
100,000g for 30 minutes at 5°C. Activity of eNOS in the super-
natant (membrane fraction) was determined by measuring the
calcium-dependent conversion of [3H]L-arginine to [3H]L-citrul-
line in the reaction mixture. The enzyme extract (25 L) was
added to 200 L of the reaction mixture containing 50 mmol/L
Tris-HCl (pH 7.4), 10 mol/L tetrahydrobiopterin, 1 mmol/L
dithiothreitol, 10 g/mL calmodulin, 4 mol/L flavin adenine
dinucleotide, 4 mol/L flavin mononucleotide, 2 mol/L L-argi-
nine, 1 Kcpm/L L-[3H] arginine, and 1 mmol/L nicotinamide
adenine dinucleotide, with or without 1 mmol/L CaCl2. After 40
minutes of incubation at 37°C, the reaction was stopped with 2 mL
of a solution containing 20 mmol/L Na acetate, pH 5.5, 1 mmol/L
L-citrulline, 2 mmol/L EDTA, and 0.2 mmol/L EGTA. The mix-
ture was applied to a 1-mL Dowex AG 50WX8 column (Dow
Chemical Company, Roissy, France), and [3H]L-citrulline was
eluted with 2 mL of distilled water. The radioactivity in the eluate
was measured using liquid scintillation spectroscopy, and the
concentration of protein in the enzyme extract was determined
according to the method of Lowry.10a
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Lung eNOS Protein
Lung eNOS protein levels were determined as previously de-
scribed.6 Tissue was homogenized on ice using a Ultraturax ho-
mogenizer (Kinematica) in 4 volumes of buffer containing 50
mmol/L Tris-HCl (pH 7.4), 0.1 mmol/L EDTA, 0.1 mmol/L
EGTA, 0.1% 2-mercaptoethanol, 1 mol/L leupeptin, 1 mol/L
pepstatin A, 1 mmol/L phenylmethylsulfonyl fluoride, and 20
mmol/L CHAPS and allowed to stand on ice for 30 minutes before
centrifugation at 3000g for 10 minutes at 5°C.
The supernatant was subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. Proteins in the gel were trans-
ferred to a nitrocellulose membrane by electroblotting in a trans-
blot Bio-Rad transfer apparatus (Bio-Rad Laboratories, Hercules,
Calif) for 12 hours at 4°C. Before the transfer, the gels, Whatman
filter paper, and nitrocellulose membrane were soaked in electro-
blotting buffer (25 mmol/L Tris-HCl; 193 mmol/L glycine; 20%
methanol, pH 8.0) for 15 minutes. After transfer, the membrane
was blocked using 1X TBST (0.15 mol/L NaCl; 10 mmol/L
Tris-HCl, pH 8.0; 0.05% Tween-20; and 5% bovine serum albu-
min) for 1 hour at room temperature. The eNOS protein was
detected by incubating the membrane overnight at 4°C with mouse
polyclonal anti-eNOS (Interchim; Asnie`res, France) diluted
1:1000. The membrane was washed 3 times in 1X TBST. Specific
protein was detected using a horseradish peroxidase-conjugated
secondary antibody and ECL reagents (Amersham, Arlington
Heights, Ill). eNOS immunoreactivity was quantified using a semi-
automated image analysis device (NIH image 1.52; Bethesda, Md)
that quantifies both the area and the intensity of immunoreactive
bands using a ScanJet II scanner with DeskScan II (Hewlett-
Packard, Palo Alto, Calif) software. Results are reported in arbi-
trary units.
Statistical Analysis
All results are reported as means  SEM. One-way analysis of
variance was performed, followed by Fisher’s test for between-
group comparisons. For the morphometric data, MT measurements
were determined by analysis of variance and Tukey’s Honestly
Significant Difference multiple comparison test; changes in pe-
ripheral muscularization were determined by the 2 test. Correla-
tions between eNOS activity and eNOS protein levels were per-
formed using simple linear regression. All statistical analyses were
performed using Statview IV (Abacus Concept, Berkeley, Calif),
Systat version 10.2 (Systat Software Inc, Richmond, Calif), or, for
the 2 test, Excel 2000 (Microsoft Corporation, Redmond, Wash).
Figure 1. Medium power light photomicrographs. Hematoxylin-eosin stain. A, Control contralateral right lung.
Normal PA adjacent to the bronchus. The arterial wall is thin, and the bronchial vessels are inconspicuous
(arrows). B, Left lung of pig in the ligated group. PA with thick wall. Adjacent to it is a large thin-walled, dilated
bronchial vessel (BA). Small part of airway lumen (lower right corner). C, Left lung of pig in revascularized group.
Part of a large PA with thin muscular wall. Adjacent to it is a bronchial vessel (arrows) with moderately thick wall.
Small part of airway lumen (lower right corner). PA, Pulmonary artery; BR, bronchus; BA, bronchial artery.
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Results
All animals in the revascularized group survived reanasto-
mosis of the ligated left PA. Pulmonary angiography
showed normal patency of the anastomosis. By use of
thoracic aortography, opacification of the left pulmonary
parenchyma (indicating the presence of bronchopulmonary
anastomoses) was consistently observed in all animals of
the ligated group but in none of the animals in the revas-
cularized group.
Total pulmonary blood flows and right PVR were similar
in the sham, ligated, and revascularized groups. Left mean
PAP values were not obtained in the ligated group, and they
were not significantly different between the revascularized
(14.4 1.2 mm Hg) and sham (12.3 0.9 mm Hg) groups.
In the revascularized animals, although there was no differ-
ence in left mean PAP values, the left PVR decreased from
21.7 1.5 mm Hg · L · min 2 days after reperfusion to 12.5
 0.9 mm Hg · L · min (P  .0009) 5 weeks after
reperfusion. The values of left PVR were lower in sham-
operated animals (5.7  0.5 mm Hg · L · min) than in
animals studied 2 days (P  .0001) or 5 weeks (P  .001)
after reperfusion.
Light Microscopy and Morphometry
Qualitatively, the vessels, airways, and parenchyma of the
contralateral right lobes of both the ligated and revascular-
ized groups were unremarkable except for a few foci of
chronic inflammation. The muscular PAs had a normally
thin media sandwiched between internal and external lam-
inae (Figure 1, A). The bronchial vessels were small and
normally distributed around airways, particularly bronchi.
In contrast, the large PAs of the pigs in the ligated group
showed medial thickening (Figure 1, B), whereas the
smaller arteries were not noticeably thicker. In addition,
there were increased and irregularly distributed bronchial
vessels that were encircling PAs and veins (particularly
bronchi), and the walls were thin. The larger PAs of the pigs
in the revascularized group were thinner on average than
those of the pigs in the ligated group (Figure 1, C). In
addition, the bronchial vessels in this group appeared to
have thicker walls than those in the ligated group, with
partial or sometimes near total occlusion of their lumina.
There was no evidence of intimal thickening of the PAs in
any of the pigs, as had been observed in canine lungs after
ligation of the PA.5
The morphometric data corroborated the qualitative de-
scriptive findings. The significant findings for the MT plot-
ted according to arterial diameter (Figure 2) occurred in the
PAs greater than 600 m in diameter. The arteries in the
ligated group showed a significantly thicker media than
those in the contralateral control right lungs of both the
ligated and revascularized groups (P  .05-.01); they were
also thicker than those of the revascularized left lobes (P 
Figure 2. Medial muscle thickness of arteries (according to diameter) in control and experimental lobes of ligated
and revascularized groups. There was a significantly increased thickness only of arteries greater than 600 m
diameter. Arteries of the revascularized lobes were not significantly different from those of the contralateral right
lobes. Ctrl, Control.
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.05), consistent with regression of the medial thickening in
this group.
Peripheral muscularization was assessed in 2 ways. First,
we calculated the proportion of each type of artery in size
categories of less than 200 m, 201 to 400 m, and greater
than 600 m. Second, we determined the percentage of each
type of artery accompanying each category of airway. There
was no evidence of increased peripheral muscularization,
although there was an unexpected significant reduction in
the muscularization of the small arteries of the ligated
compared with the contralateral control side.
Isolated Left PA Ring Study
Maximal contraction to U46619 was higher in the sham
group than in the revascularized and ligated groups (5729
245 mg vs 2514  422 mg, P  .001 and 5729  245 mg
vs 1853  431 mg, P  .0001, respectively). The U46619
EC50 was similar in the 3 groups.
The relaxation response to sodium nitroprusside was not
affected by PA ligation or reperfusion. Maximal relaxation
in response to acetylcholine (Figure 3, A) was lower in the
ligated group than in the revascularized (P  .04) and sham
(P  .007) groups, and higher in the sham group than in the
revascularized group (P  .05). No differences in the ace-
tylcholine EC50 were seen between the 3 groups.
Maximal relaxation in response to calcium ionophore
(Figure 3, B) was lower in the ligated group than in the
revascularized (P  .01) and sham (P  .0003) groups, and
higher in the sham group than in the revascularized group (P
 .04). The EC50 to calcium ionophore was higher in the
chronic ischemia group than in the reperfused and sham
groups (1.44.106  6.6.107 mol/L vs 1.71.107 
5.7.108 mol/L, P  .01; and 1.44.106  6.6.107 mol/L
vs 1.39.108  1.9.109 mol/L, P  .01, respectively).
eNOS Activity
The calcium-dependent NOS activity in the left lungs of the
ligated group was lower than in the sham and revascularized
groups, and there were no differences between the sham and
revascularized groups (Figure 4, A). Calcium-independent
NOS activity of the left lung was similar in the 3 groups.
Figure 3. Percent reduction of maximal contraction to (left) phenylephrine produced by acetylcholine stimulation
and (right) U46619 produced by calcium ionophore stimulation of PA rings derived from left lungs 5 weeks after PA
ligation (ligated group) and 5 weeks after PA reperfusion (revascularized group) compared with sham. Results are
presented as mean  SEM. The concentration-response curves were significantly reduced in the ligated group
compared with the other groups. However, the concentration-response curves recovered incompletely in the
revascularized group compared with the sham group.
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Left Lung eNOS Protein Levels
The eNOS protein level in the left lungs of the ligated group
was lower than in the sham and revascularized groups, and
there was no difference between the sham and revascular-
ized groups. Left pulmonary calcium-dependent NOS ac-
tivity and eNOS protein levels were linearly correlated (r 
.70, P  .0033); the higher the level of protein, the higher
the activity.
Discussion
Pulmonary thromboendarterectomy is an effective surgical
procedure to reduce PVR in patients with longstanding
obstruction of the central PAs.1,2 The postoperative PVR
levels, however, remain higher than normal and progres-
sively decrease in time.4 In a piglet model of chronic left PA
obstruction, we showed that the progressive improvement
of PVR after lung revascularization by reimplantation of the
left PA reflects the slow regression of the structural and
functional alterations that develop in the pulmonary vascu-
lar bed during lung ischemia.
Chronic thromboembolic obstruction of the PAs in hu-
mans can be reproduced in experimental animals by chronic
unilateral ligation of a PA. Our previous ex vivo studies
showed that PVR distal to the site of ligation increased in
dogs5 and piglets6,7 after long-term lung ischemia. To ex-
tend these findings to in vivo conditions, we developed an
animal model in which the left lung was reperfused by
reimplantation of the left PA end-to-side into the PA trunk
after a period of chronic left PA ligation. At 2 days after
reperfusion of the previously ligated left lung, we found a
4-fold elevation in the PVR compared with normal. This
increase was not explained by a persistent obstruction of the
left PA because the reanastomosed PAs were patent at the
end of the procedure, as confirmed by angiography and
subsequently by direct visual inspection; neither was this
increase in PVR caused by ischemia-reperfusion injury of
the left lung because it was markedly attenuated in this
model of chronic lung ischemia compared with acute isch-
emia.7 Rather, we believe that this increase in PVR was
related to the functional and structural alterations that de-
velop distal to the obstruction of the distal vascular bed.
As reported in our previous studies in piglets, dogs, and
rats,5-7,11,12 postobstructive pulmonary vasculopathy is
characterized by (1) a marked increase in collateral bron-
chial blood flow through bronchial to pulmonary precapil-
lary anastomoses; (2) a prominent increase in pulmonary
vasoreactivity associated with a decrease in eNOS activity,
eNOS protein expression, and eNOS-dependent relaxation
of the left PAs; and (3) structural changes that include
proliferation of new bronchial vessels and an increase in PA
MT. Similar functional and morphologic vascular changes
have been described in the lungs of patients with chronic
Figure 4. Left lung eNOS activities and protein content 5 weeks after left PA ligation, PA reperfusion, and sham
operation. There were no significant differences after 5 weeks between PA reperfusion and sham groups. Results
are presented as mean  SEM. eNOS, Endothelial nitric oxide synthase.
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thromboembolic obstruction of the PAs.13 The mechanisms
responsible for this pulmonary postobstructive vasculopathy
remain unclear. We suspect that ischemic injury to the distal
pulmonary parenchyma initiates a complex sequence of
events including endothelial cell damage, local release of
inflammatory mediators, and angiogenic factors that induce
remodeling of the PAs, bronchial artery proliferation, and
endothelial dysfunction.
It was unknown until now whether the alterations char-
acteristic of postobstructive pulmonary vasculopathy are
reversible after reperfusion of the chronically ischemic
lung. Our animal model of in vivo reperfusion offers a
unique opportunity to test this hypothesis. Indeed, we ob-
served a marked regression of both the functional and
morphologic abnormalities of the left lung after 5 weeks of
reperfusion, specifically, the bronchial-to-pulmonary anas-
tomoses and the normal PA remodeling. In addition, the
activity and expression of the left pulmonary eNOS also
improved in parallel toward normal values; in contrast,
recovery of pulmonary vasoreactivity was incomplete in the
reperfused lung. The sum total of these findings might
account for the reduction in left pulmonary PVR to values
intermediate between those of ischemic and normal lungs.
Our study has important implications. Progressive long-
term improvements in PVR have been observed in patients
with chronic thromboembolic pulmonary hypertension after
reestablishment of the pulmonary circulation in the previ-
ously obstructed vascular bed. Because our model ade-
quately reproduces the morphologic and functional changes
in vasculature seen in humans in the postobstructive pul-
monary vascular bed, we believe that long-term improve-
ment in PVR after pulmonary thromboendarterectomy sim-
ilarly mirrors the regression of this vasculopathy. Moreover,
in patients with the most severe forms of postembolic pul-
monary hypertension, thromboendarterectomy may fail to
lower PVR because of an extensive postobstructive pulmo-
nary vasculopathy, thereby increasing the risk of postoper-
ative morbidity and mortality.14 In these patients, a recent
study indicates that chronic prostacyclin administration be-
fore thromboendarterectomy decreases postoperative
PVR.15 This treatment may be effective not only by dilating
the pulmonary vasculature but also by inhibiting vascular
growth and remodeling.
Conclusion
In a piglet model of chronic left PA obstruction, this study
showed that the progressive improvement of PVR after lung
revascularization by reimplantation of the left PA reflects
the slow regression of the structural and functional alter-
ations that develop in the pulmonary vascular bed during
lung ischemia.
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Discussion
Dr Andrew S. Wechsler (Philadelphia, Pa). I am curious
about the analogy of this particular model to that of thromboem-
bolic vasculopathy. It seems to me the latter is really associated
with a huge inflammatory response (the release of local cytokines
and inflammatory factors) and a very different proliferative sort of
phenomenon. Your study is very interesting regardless of the
analogy, but to extend your conclusion to there being a mechanism
involved after pulmonary endarterectomy might be reaching a little
far. How would you defend that?
Dr Fadel. In fact, our aim was to study the postobstructive
vascular bed and not the remaining perfused PA bed. We observed
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a hypertrophied systemic blood supply to the lung, and one of us,
Dr Rene Michel, has already shown that the PVR was increased in
the postobstructive bed. We believe that our animal model repro-
duces the pathologic changes observed in human postembolic
pulmonary vasculopathy. Local release of proinflammatory medi-
ators and angiogenic factors is likely because we observed an
increased production of vascular endothelial growth factor in the
acute ischemic lung (unpublished data; Fadel E, MD, 2000).
Dr Frank L. Hanley (Stanford, Calif). Dr Wechsler’s com-
ments notwithstanding, these observations may have more appli-
cation to many congenital problems in which we see iatrogenic or
non-iatrogenic occluded PAs that may need reconstruction after
long periods of complete occlusion.
In regard to the vascular resistance decrease, there could be 2
factors involved. When these arteries are occluded for long periods
of time, the conduit component of the artery becomes hypoplastic
because there’s no flow in it. If you reperfuse the artery acutely
with reanastomosis, those arteries don’t immediately achieve a
normal diameter, so there is going to be significant resistance along
the conduit portion before you get to the microvasculature. Do you
know whether your decrease in resistance is a result of gradual
reestablishment of normal diameter of the conduit component or
whether there are real changes in the small arterioles that lead to
the decrease?
Dr Fadel. This is a very interesting question. We agree that the
large PAs beyond the ligation site are hypoplastic, but we didn’t
find any difference in diameter of the small PAs between the
control, ligated, or reperfused groups. The distal PA bed seems
somewhat preserved and reperfused by the bronchial circulation.
However, PVR mainly depends on the distal vascular bed. So, we
believe that the decrease of PVR, after the decrease observed
postoperatively, is related to changes that occurred in the micro-
vascular system.
Dr Randall B. Griepp (New York, NY). Did any of these
animals have reperfusion pulmonary edema? And if they did, can
you say anything about how much media, how much musculature
in the media, was left in those animals that did have edema?
Dr Fadel. In this study, the lung was studied 5 weeks after
reperfusion, so we did not find any pulmonary edema in the
reperfused lung. In previous studies, we found a pulmonary edema
when the lung was studied immediately after reperfusion of the
ligated PA. We also found the same edema when the lung was
reperfused using an endarterectomy through the media of a previ-
ously obstructed PA by an adherent thrombus. We don’t believe
that the endarterectomy of the proximal PA bed could be respon-
sible for the pulmonary edema. Indeed, it seems a real reperfusion
edema.
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